解读与SARS-CoV-2感染相关的帕金森病中多巴胺基神经元损伤背后的分子通路
Qiuhan Xu1, Sisi Jiang1, Ruiqing Kang1
1Department of Neurology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, People's Republic of China.
Computers in biology and medicine
|March 1, 2024
概括
这项研究揭示了多巴胺基神经元中COVID-19和帕金森病 (PD) 之间的共同途径,将CD38确定为生物标志物和基因素作为两种条件的潜在双重治疗剂.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 计算生物学 计算生物学
背景情况:
- 随着COVID-19大流行,神经系统疾病,包括帕金森病 (PD) 存在风险.
- 连接SARS-CoV-2感染与PD病变的机制尚不清楚.
研究的目的:
- 在多巴胺基 (DA) 神经元中调查COVID-19和PD之间的共享分子通路.
- 确定两种疾病的潜在生物标志物和治疗点.
主要方法:
- 来自COVID-19和PD患者的DA神经元的转录组分析.
- 构建蛋白质-蛋白质相互作用和基因调节网络.
- 机器学习用于疾病诊断/进展模型和药物发现.
主要成果:
- 确定了DA神经元中常见的通路和差异表达的基因.
- CD38已成为一个潜在的关键生物标志物.
- 吉尼斯作为PD和COVID-19的双重治疗剂显示出希望.
结论:
- 在DA神经元中阐明了COVID-19和PD之间的常见病原体.
- 在COVID-19大流行中提供PD研究和治疗的新策略.
相关概念视频
Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


